Navigation Links
Rigel Announces First Quarter Financial Results
Date:5/3/2011

are delighted by the progress AstraZeneca has made with the fostamatinib phase 3 program," said James M. Gower, chairman and chief executive officer of Rigel. "We currently expect to begin two phase 1 clinical trials with our internal JAK3 programs by the end of 2011. The first is a novel oral JAK3 inhibitor intended for the treatment of transplant rejection and the second is a different JAK3 inhibitor in a topical formulation intended for the treatment of discoid lupus," he added.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 clinical trials for asthma.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's expectations as to its year-end cash position and the sufficiency of its cash, cash equivalents and available for sale securities; and identification of a novel programs for clinical development, the potential indications for treatment, and the timing of clinical trials with respect thereto.  Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as " "intend," "expect," and similar expressions are intended to identify these forward-looking statements. These forward-looking statement
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
2. Rigel to Present at Three Upcoming Investor Conferences
3. Rigel Announces Participation at Two Investor Conferences
4. Rigel to Present at JP Morgan Healthcare Conference
5. Rigel Announces Third Quarter 2009 Financial Results
6. Rigel Announces Presentations at Two Investor Conferences
7. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
8. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
9. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
10. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
11. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... July 2, 2015 ResMed Inc. (NYSE: RMD ... and fiscal year ended June 30, 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... 50% Survival in Valortim-Treated,Animals , PRINCETON, N.J. ... Medarex,Inc. (Nasdaq: MEDX), a leading monoclonal antibody ... company dedicated,to the development of biodefense countermeasures, ... antibody product candidate,being developed for the prevention ...
... to Guard Against,Hospital Infections, KANSAS CITY, Kan., April ... top ten leading causes of death in the,United ... There,are countless stories about patients who go into ... circumstances. As a,patient, knowing the right questions to ...
Cached Medicine Technology:Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Six Important Things to Know About Preventing Hospital Infections 2Six Important Things to Know About Preventing Hospital Infections 3
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie ... 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of ... and practical points of investigating these types of cases. , Each year, New ...
(Date:7/3/2015)... Louis, MO (PRWEB) , ... July 03, 2015 , ... ... responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... Medical Director of its Frisco facility. , “We are pleased to announce that Dr. ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... that he says will reveal biblical truth and expose popular lies regarding proper relationships ... Say Don’t Have Sex”, immediately goes into the core of the subject by explaining ...
Breaking Medicine News(10 mins):Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... , NEW YORK, Sept. 22 Reportlinker.com announces ... catalogue. , , Cell Culture: ... , , http://www.reportlinker.com/p0116159/Cell-Culture-The-World-Market-for-Media-Sera-and-Reagents-2nd-Edition.html ... foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical ...
... New federal law may help deter young smokers, health advocates ... who enjoy a hint of vanilla, berry or chocolate when ... snuffed out. A new federal law banning fruit- and candy-flavored ... of the Family Smoking Prevention and Tobacco Control Act, legislation ...
... , NEW YORK, Sept. 22 FiLife ( ... online, today announced that public concerns about costs dominated its "Fix ... As President Obama continues to push for healthcare reform, ... a joint venture between Dow Jones & Company and IAC (Nasdaq: ...
... ... is now available online, featuring an extensive video documentary of ACE09, the Allscripts Client ... Palm ... LLC announced today that its new Allscripts Channel is now available online, featuring an ...
... , , NEW YORK, ... report is available in its catalogue. , ... Endoscopy Equipment , http://www.reportlinker.com/p099452/The-World-Market-for-Gastrointestinal-Endoscopy-Equipment.html ... market is a market on the rise. With continually advancing ...
... NEW YORK, Sept. 22 Reportlinker.com announces ... catalogue. Wound Care Markets, 4th. Edition, Vol. ... care is a constantly changing market. New wound care products ... the most painful and critical of injuries, all striving for ...
Cached Medicine News:Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 2Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 3Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 4Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 5Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 6Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 7Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 8Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 9Health News:Flavored Cigarette Ban Takes Effect 2Health News:Flavored Cigarette Ban Takes Effect 3Health News:FiLife's 'Fix Healthcare in Three Words' Twitter Contest Reveals Money is the Key Issue 2Health News:EHRtv.com Introduces Allscripts Channel Featuring Presentations, Client Interviews and Keynote from National User Conference 2Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 2Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 3Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 4Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 5Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 6Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 7Health News:Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 8Health News:Reportlinker Adds Wound Care Markets, 4th. Edition, Vol. II: Burns Report 2Health News:Reportlinker Adds Wound Care Markets, 4th. Edition, Vol. II: Burns Report 3
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8590. Model 8590 is UL Listed, C...
... precise requirements of blood banking and ... Equipment meets American Association of Blood ... (ANRC) and U.S. Food & Drug ... and platelet incubators feature alarm systems ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
... the precise requirements of blood banking ... Bank Equipment meets American Association of ... Cross (ANRC) and U.S. Food & ... freezers, and platelet incubators feature alarm ...
Medicine Products: